A Clinical Study of KTX-2001 in Subjects With Metastatic Castration-Resistant Prostate Cancer (STRIKE-001)

Clinical trial NCT07103018 · RECRUITING

Trial details

NCT number: NCT07103018
Sponsor: K36 Therapeutics, Inc.
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Metastatic Castration-resistant Prostate Cancer Metastatic Castration-Resistant Prostate Cancer Patients Metastatic Castration-resistant Prostate Cancer, mCRPC mCRPC mCRPC (Metastatic Castration-resistant Prostate Cancer)

Start date: 2025-11-21
Primary completion: 2027-09-01
Enrollment: 144

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.